Edit Picture
Renaissance Capital IPO Research
- on IPO Analysis
Renaissance Capital IPO Research
Stop FollowingRenaissance Capital IPO Research
Renaissance Capital’s research analysts provide unbiased and comprehensive coverage of the U.S. and international IPO markets. Through Renaissance Capital’s research service, clients get a hard-nosed, independent opinion, in-depth fundamental analysis and customizable financial models on all... More
- My company:
- Renaissance Capital LLC
- My blog:
- IPO News from Renaissance Capital
- My book:
- IPOs for Everyone
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
-
Instablogged Stocks
Stocks that instabloggers have most recently written about -
Latest Instablog Posts
- 1 The Case For NOKIA...
- 2 The Nasdaq Is Just 2.4% Below My Semiannual ...
- 3 Add Some Oil To Your Portfolio For Value & G...
- 4 Riverbed Technology, Inc. - Value Alert
- 5 Wynn Resorts Limited
-
Top Instablogs
See all Top Instablogs »









Three more companies set IPO terms, six deals scheduled to price Thursday night 0 comments
Chesapeake, which has no operating history to date, previously filed to go public and was set to begin trading on Dec. 8, 2009, along with Pebblebrook Hotel Trust (PEB). While Pebblebrook raised $350 million in its IPO, Chesapeake shelved its deal; its new terms trim the deal size by 40% (7.5 million shares at $20 instead of 12.5 million shares). The IPO is scheduled to price this Thursday, Jan. 21, along with five other companies: China Hydroelectric (CHC), Andatee Marine China Fuel (AMCF), Terreno Realty (TRNO), Symetra Financial (SYA) and Cellu Tissue Holdings (CLU).
Patriot Risk Management (PMG), which also filed terms yesterday, plans to raise $187 million by offering 17 million shares at a price range of $10-$12. The insurance company had previously filed terms on Oct. 2, 2008, offering 15 million shares at the same price range; it removed these terms on Nov. 9, 2009, several months after it was acquired by Inter-Atlantic Financial, a SPAC that went public in October of 2007. Patriot plans to list on the NYSE during the week of Feb. 1.
The third company to recently announce terms, Ironwood Pharmaceuticals (IRWD), is also slated to price that week. Ironwood, which is based in Cambridge, MA, plans to raise $250 million by offering 16.7 million class A shares at a price range of $14-$16. The early stage company has yet to develop or commercialize any products; however, its pipeline includes one Phase 3 drug candidate (linaclotide), one Phase 1 pain drug and several preclinical programs.
Recent filing activity and a full docket of upcoming deals indicate the IPO market is already poised for a healthy recovery in 2010.
Disclosure: No positions
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
Share this Instablog
Latest Followers
Posts by Themes